Formulation of Docetaxel using Prodrugs for Intravenous Delivery
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김진기 | - |
dc.date.accessioned | 2025-04-01T06:32:32Z | - |
dc.date.available | 2025-04-01T06:32:32Z | - |
dc.date.issued | 2012-07-17 | - |
dc.identifier.issn | 0037-8984 | - |
dc.identifier.issn | 1777-5469 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/122694 | - |
dc.title | Formulation of Docetaxel using Prodrugs for Intravenous Delivery | - |
dc.type | Conference | - |
dc.citation.title | Proceedings of the Controlled Release Society | - |
dc.citation.startPage | 366 | - |
dc.citation.endPage | 367 | - |
dc.citation.conferencePlace | 프랑스 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.